COVID-19

Sperm Parameters Before and After COVID-19 mRNA Vaccination

Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

Tofacitinib in Patients Hospitalized with COVID-19 Pneumonia

Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes

Treatment of Multisystem Inflammatory Syndrome in Children

For July 2021, we have selected: Greinacher A. et al, Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840.

6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records

Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients

Estimating COVID-19 mortality in Italy early in the COVID-19 pandemic

Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study

A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications

COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2